In vitro diagnostics are tests done on samples such as blood or tissue that have been taken from the human body. In vitro diagnostics can detect diseases or other conditions, and can be used to monitor a person’s overall health to help cure, treat, or prevent diseases.
In vitro diagnostics may also be used in precision medicine to identify patients who are likely to benefit from specific treatments or therapies. These in vitro diagnostics can include next generation sequencing tests, which scan a person’s DNA to detect genomic variations.
Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.
Scope of the Report:
This report studies the In-vitro Diagnostic Services market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the In-vitro Diagnostic Services market by product type and applications/end industries.
The global In-vitro Diagnostic Services market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of In-vitro Diagnostic Services.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
BioRad
DexCom
Nova Biomedical
OraSure
Pearl Pathways
Phenomenex
Qiagen
Roche Diagnostics
Siemens
Sysmex
Thermofisher
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Infectious Testing
Diabetes Testing
Molecular Testing
Tissue Testing
Market Segment by Applications, can be divided into
Hospitals
Point-Of-Care Testing
Laboratories
Academic Institutes
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 In-vitro Diagnostic Services Market Overview
1.1 Product Overview and Scope of In-vitro Diagnostic Services
1.2 Classification of In-vitro Diagnostic Services by Types
1.2.1 Global In-vitro Diagnostic Services Revenue Comparison by Types (2017-2023)
1.2.2 Global In-vitro Diagnostic Services Revenue Market Share by Types in 2017
1.2.3 Infectious Testing
1.2.4 Diabetes Testing
1.2.5 Molecular Testing
1.2.6 Tissue Testing
1.3 Global In-vitro Diagnostic Services Market by Application
1.3.1 Global In-vitro Diagnostic Services Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hospitals
1.3.3 Point-Of-Care Testing
1.3.4 Laboratories
1.3.5 Academic Institutes
1.4 Global In-vitro Diagnostic Services Market by Regions
1.4.1 Global In-vitro Diagnostic Services Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) In-vitro Diagnostic Services Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) In-vitro Diagnostic Services Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) In-vitro Diagnostic Services Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) In-vitro Diagnostic Services Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) In-vitro Diagnostic Services Status and Prospect (2013-2023)
1.5 Global Market Size of In-vitro Diagnostic Services (2013-2023)
2 Manufacturers Profiles
2.1 BioRad
2.1.1 Business Overview
2.1.2 In-vitro Diagnostic Services Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 BioRad In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.2 DexCom
2.2.1 Business Overview
2.2.2 In-vitro Diagnostic Services Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 DexCom In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.3 Nova Biomedical
2.3.1 Business Overview
2.3.2 In-vitro Diagnostic Services Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Nova Biomedical In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.4 OraSure
2.4.1 Business Overview
2.4.2 In-vitro Diagnostic Services Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 OraSure In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.5 Pearl Pathways
2.5.1 Business Overview
2.5.2 In-vitro Diagnostic Services Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Pearl Pathways In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.6 Phenomenex
2.6.1 Business Overview
2.6.2 In-vitro Diagnostic Services Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Phenomenex In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.7 Qiagen
2.7.1 Business Overview
2.7.2 In-vitro Diagnostic Services Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Qiagen In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.8 Roche Diagnostics
2.8.1 Business Overview
2.8.2 In-vitro Diagnostic Services Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Roche Diagnostics In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.9 Siemens
2.9.1 Business Overview
2.9.2 In-vitro Diagnostic Services Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Siemens In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.10 Sysmex
2.10.1 Business Overview
2.10.2 In-vitro Diagnostic Services Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sysmex In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
2.11 Thermofisher
2.11.1 Business Overview
2.11.2 In-vitro Diagnostic Services Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Thermofisher In-vitro Diagnostic Services Revenue, Gross Margin and Market Share (2016-2017)
3 Global In-vitro Diagnostic Services Market Competition, by Players
3.1 Global In-vitro Diagnostic Services Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 In-vitro Diagnostic Services Players Market Share
3.2.2 Top 10 In-vitro Diagnostic Services Players Market Share
3.3 Market Competition Trend
4 Global In-vitro Diagnostic Services Market Size by Regions
4.1 Global In-vitro Diagnostic Services Revenue and Market Share by Regions
4.2 North America In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
4.3 Europe In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
4.5 South America In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
5 North America In-vitro Diagnostic Services Revenue by Countries
5.1 North America In-vitro Diagnostic Services Revenue by Countries (2013-2018)
5.2 USA In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
5.3 Canada In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
5.4 Mexico In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
6 Europe In-vitro Diagnostic Services Revenue by Countries
6.1 Europe In-vitro Diagnostic Services Revenue by Countries (2013-2018)
6.2 Germany In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
6.3 UK In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
6.4 France In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
6.5 Russia In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
6.6 Italy In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
7 Asia-Pacific In-vitro Diagnostic Services Revenue by Countries
7.1 Asia-Pacific In-vitro Diagnostic Services Revenue by Countries (2013-2018)
7.2 China In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
7.3 Japan In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
7.4 Korea In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
7.5 India In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
8 South America In-vitro Diagnostic Services Revenue by Countries
8.1 South America In-vitro Diagnostic Services Revenue by Countries (2013-2018)
8.2 Brazil In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
8.3 Argentina In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
8.4 Colombia In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue In-vitro Diagnostic Services by Countries
9.1 Middle East and Africa In-vitro Diagnostic Services Revenue by Countries (2013-2018)
9.2 Saudi Arabia In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
9.3 UAE In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
9.4 Egypt In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
9.5 Nigeria In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
9.6 South Africa In-vitro Diagnostic Services Revenue and Growth Rate (2013-2018)
10 Global In-vitro Diagnostic Services Market Segment by Type
10.1 Global In-vitro Diagnostic Services Revenue and Market Share by Type (2013-2018)
10.2 Global In-vitro Diagnostic Services Market Forecast by Type (2018-2023)
10.3 Infectious Testing Revenue Growth Rate (2013-2023)
10.4 Diabetes Testing Revenue Growth Rate (2013-2023)
10.5 Molecular Testing Revenue Growth Rate (2013-2023)
10.6 Tissue Testing Revenue Growth Rate (2013-2023)
11 Global In-vitro Diagnostic Services Market Segment by Application
11.1 Global In-vitro Diagnostic Services Revenue Market Share by Application (2013-2018)
11.2 In-vitro Diagnostic Services Market Forecast by Application (2018-2023)
11.3 Hospitals Revenue Growth (2013-2018)
11.4 Point-Of-Care Testing Revenue Growth (2013-2018)
11.5 Laboratories Revenue Growth (2013-2018)
11.6 Academic Institutes Revenue Growth (2013-2018)
12 Global In-vitro Diagnostic Services Market Size Forecast (2018-2023)
12.1 Global In-vitro Diagnostic Services Market Size Forecast (2018-2023)
12.2 Global In-vitro Diagnostic Services Market Forecast by Regions (2018-2023)
12.3 North America In-vitro Diagnostic Services Revenue Market Forecast (2018-2023)
12.4 Europe In-vitro Diagnostic Services Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific In-vitro Diagnostic Services Revenue Market Forecast (2018-2023)
12.6 South America In-vitro Diagnostic Services Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa In-vitro Diagnostic Services Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure In-vitro Diagnostic Services Picture
Table Product Specifications of In-vitro Diagnostic Services
Table Global In-vitro Diagnostic Services and Revenue (Million USD)